5 completed, 3 terminated, 1 unknown. 9 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 5, Terminated 3, Unknown 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow ropinirole: new trials by email Literature Review of ropinirole trials Research Report on ropinirole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Ropinirole and Gabapentin for the Treatment of RLS in Patients on Maintenance HD Ropinirole, Gabapentin, Placebos - Restless Legs Syndrome, End Stage Renal Disease | Phase 2 | Terminated | University of Alberta | 3 | 2019-02-19 | 2022-07-12 |
| Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole Ropinirole oral product, Ropinirole Implant - Parkinson Disease | Phase 1 / Phase 2 | Terminated | Titan Pharmaceuticals | 6 | 2017-10-10 | 2023-05-06 |
| Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole Ropinirole - Hyperprolactinemia, Prolactinoma | Phase 1 / Phase 2 | Completed | Columbia University | 16 | 2016-09-16 | 2024-06-04 |
| Cognitive Remediation for Cocaine Dependence levodopa/carbidopa, Ropinirole 2 mg/d, Placebo - Cocaine Dependence | Phase 2 | Completed | The University of Texas Health Science Center, Houston | 119 | 2011-06-01 | 2018-03-29 |
| Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration) Ropinirole immediate release (IR), Placebo - Restless Legs Syndrome | Phase 2 | Terminated | GlaxoSmithKline | 34 | 2009-11-30 | 2018-08-10 |
| Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type Ropinirole - Unverricht-Lundborg Syndrome | Phase 2 | Unknown | University of Turku | 16 | 2007-08-01 | 2008-03-19 |
| Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole Ropinirole - Parkinson Disease | Phase 2 | Completed | GlaxoSmithKline | 28 | 2007-04-01 | 2016-10-28 |
| Fibromyalgia Study In Adults ropinirole - Fibromyalgia Syndrome, Primary | Phase 2 | Completed | GlaxoSmithKline | 164 | 2004-11-01 | 2016-09-15 |
| Trial of Ropinirole in Motor Recovery After Stroke Ropinirole (+ physical therapy), (vs.) Placebo + physical therapy - Cerebrovascular Accident, Hemiparesis | Phase 2 | Completed | University of California, Irvine | 52 | 2003-10-01 | 2016-11-01 |
Parkinson Disease (2) · Restless Legs Syndrome (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cocaine-Related Disorders (1) · Dyskinesias (1) · Fibromyalgia (1) · Hyperprolactinemia (1) · Kidney Failure, Chronic (1) · Movement Disorders (1) · Neurodegenerative Diseases (1) · Pain (1) · Paresis (1) · Parkinsonian Disorders (1) · Prolactinoma (1)
GlaxoSmithKline (3) · Columbia University (1) · The University of Texas Health Science Center, Houston (1) · Titan Pharmaceuticals (1) · University of Alberta (1) · University of California, Irvine (1) · University of Turku (1)
United States (4) · Finland (2) · Germany (2) · Belgium (1) · Canada (1) · Denmark (1) · France (1) · Italy (1) · Japan (1) · Netherlands (1) · South Africa (1) · Sweden (1) · United Kingdom (1)
Dr. Kate Beebe DeVarney (1) · Gabrielle Page-Wilson, M.D. (1) · Steven C Cramer, MD (1)
PMID 19520987, PMID 34600245, PMID 37715962
R21DK112093 (1)